Evaluation of Semiquantitative Assessments of Fluorodeoxyglucose Uptake on Positron Emission Tomography Scans for the Diagnosis of Pulmonary Malignancies 1 to 3 cm in Size

Annals of Thoracic Surgery

Volumn 87, Issue 3, 2009, Pages 886-891

  Ohba, Yasuomi ^a   Nomori, Hiroaki ^a,c   Shibata, Hidekatsu ^a   Kobayashi, Hironori ^a   Mori, Takeshi ^a   Shiraishi, Shinya ^a   Nakashima, Rumi ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

^c Tokyo Medical and Dental University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CEREBELLUM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FALSE NEGATIVE RESULT; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADENOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 60449111488     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.09.081     Document Type: Article

References (27)

1. Scott W.J., Schwabe J.L., Gupta N.C., et al. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F] fluorodeoxyglucose. Ann Thorac Surg 58 (1994) 698-703
2. Patz E.F., Lowe V.J., Hoffman J.M., et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188 (1993) 487-490
3. Gupta N.C., Maloof J., and Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 37 (1996) 943-948
4. Gambhir S.S., Shepherd J.E., Shah B.D., et al. Analytical decision model for the cost-effectiveness management of solitary pulmonary nodules. J Clin Oncol 16 (1998) 2113-2125
5. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., and Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 45 (2004) 19-27
6. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., and Uno K. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 127 (2004) 1087-1092
7. Lowe V.J., Hoffman J.M., DeLong D.M., Patz E.F., and Coleman R.E. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 35 (1994) 1771-1776
8. Zasadny K.R., and Wahl R.L. Standarized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 189 (1993) 847-850
9. Kim C.K., Gupta N.C., Chandramouli B., and Alavi A. Standarized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med 35 (1994) 164-167
10. Kim C.K., and Gupta N.C. Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction. Nucl Med Commun 17 (1996) 890-894
11. Lindholm P., Minn H., Leskinen-Kallio S., Bergman J., Ruotsalainen U., and Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer: a PET study. J Nucl Med 34 (1993) 1-6
12. Langen K.J., Braun U., Rota Kops E., et al. The influence of plasma glucose levels of fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 34 (1993) 355-359
13. Hamberg L.M., Hunter G.I., Alpert N.M., Choi N.C., Babich J.W., and Fischman A.J. The dose uptake ratio as an index of glucose metabolixm: useful parameter or oversimplification?. J Nucl Med 35 (1994) 1308-1312
14. Cremerius U., Fabry U., Neuerburg J., Zimny M., Osieka R., and Buell U. Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma. Nucl Med Commun 19 (1998) 1055-1063
15. Menda Y., Bushnell D.L., Madsen M.T., McLaughlin K., Kahn D., and Kernstine K.H. Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy. Nucl Med Commun 22 (2001) 1077-1081
16. Dewan N.A., Gupta N.C., Redepenning L.S., et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 104 (1993) 997-1002
17. Imdahl A., Jenkner S., Brink I., et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardiothorac Surg 20 (2001) 324-329
18. Lowe V.J., Fletcher J.W., Gobar L., et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16 (1998) 1075-1084
19. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., and Uno K. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose (FDG) PET scanning in pulmonary nodules 1 to 3 cm in size. Ann Thorac Surg 79 (2005) 984-988
20. Obrzut S., Pham R.H., Vera D.R., Badran K., and Hoha C.K. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET. Nucl Med 27 (2007) 7-13
21. Travis M., Colvy T., Corrin B., et al. World Health Organization international histological classification of tumors. Histological typing of lung and pleural tumors. 3rd ed. (1999), Springer-Verlag, Berlin
22. Sobin L.W., and Witteking C.H. UICC TMN classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York 131-141
23. Wahl R.L., Cody R.L., Hutchins G.D., et al. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 179 (1991) 765-770
24. Watanabe K., Nomori H., Ohtsuka T., et al. [F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Jpn J Clin Oncol 36 (2006) 403-409
25. Uno K., Yoshikawa K., Imazeki K., Okada J., Minoshima S., and Arimizu N. FDG-PET evaluation of breast carcer: a diagnostic role for primary or metastatic and recurrent lesions. Radiology 185 (1992) 108
26. Higashi K., Ueda Y., Seki H., et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar carcinoma. J Nucl Med 39 (1998) 1016-1020
27. Coleman R.E. PET in lung cancer. J Nucl Med 40 (1999) 814-820